Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
Saved in:
| Title: | Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial. |
|---|---|
| Authors: | Jifang Gong1, Tianshu Liu2, Qingxia Fan3, Li Bai4, Feng Bi5, Shukui Qin6, Jinwan Wang7, Nong Xu8, Ying Cheng9, Yuxian Bai10, Wei Liu11, Liwei Wang12, Lin Shen1 lin100@medmail.com.cn, Gong, Jifang13 (AUTHOR), Liu, Tianshu2 (AUTHOR), Fan, Qingxia3 (AUTHOR), Bai, Li4 (AUTHOR), Bi, Feng5 (AUTHOR), Qin, Shukui6 (AUTHOR), Wang, Jinwan14 (AUTHOR) |
| Source: | BMC Cancer. 2/8/2016, Vol. 16, p1-9. 9p. 1 Diagram, 2 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
